Inflammatory bowel disease and the risk of fracture after controlling for FRAX

Journal of Bone and Mineral Research

Volumn 28, Issue 5, 2013, Pages 1007-1013

  Targownik, Laura E ^a   Bernstein, Charles N ^a   Nugent, Zoann ^b   Johansson, Helena ^c   Oden, Anders ^c   McCloskey, Eugene ^d   Kanis, John A ^c   Leslie, William D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bone Mineral Density; Fracture; FRAX; Inflammatory Bowel Disease; Osteoporosis; Population based

Indexed keywords

GLUCOCORTICOID;

ADULT; ARTICLE; BONE DENSITY; CANADA; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR NECK; FEMUR NECK FRACTURE; FRACTURE RISK ASSESSMENT TOOL; FRAGILITY FRACTURE; HAZARD RATIO; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; MAJOR OSTEOPOROTIC FRACTURE; MALE; MEDICAL INFORMATION; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPINE FRACTURE; ULCERATIVE COLITIS; WRIST FRACTURE;

AGED; BONE DENSITY; FRACTURES, BONE; HUMANS; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; PROBABILITY; RISK ASSESSMENT;

EID: 84876697692     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1848     Document Type: Article

References (34)

1. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A., Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20 (7): 1185-94.
2. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD., Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007; 177 (6): 575-80.
3. Marshall D, Johnell O, Wedel H., Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996; 312 (7041): 1254-9.
4. Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR., Osteoporotic Fractures Research Group. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003; 18 (11): 1947-54.
5. Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML., Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004; 164 (10): 1108-12.
6. Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J., Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA. 2007; 298 (20): 2389-98.
7. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N., Assessment of fracture risk. Osteoporos Int. 2005; 16 (6): 581-9.
8. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N., The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18 (8): 1033-46.
9. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA., Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res. 2010; 25 (11): 2350-8.
10. Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD., FRAX® with and without bone mineral density. Calcif Tissue Int. 2012; 90 (1): 1-13.
11. Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA., FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2012; 27 (2): 301-8.
12. Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM., Study of Osteoporotic Fractures (SOF) Research Group; Osteoporotic Fractures in Men (MrOS) Research Group; Health, Aging, and Body Composition (Health ABC) Research Group. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011; 305 (21): 2184-92.
13. Leslie WD, Rubin MR, Schwartz AV, Kanis JA., Type 2 diabetes and bone. J Bone Miner Res. 2012; 27 (11): 2231-7.
14. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN., The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000; 133 (10): 795-9.
15. van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK., Inflammatory bowel disease and the risk of fracture. Gastroenterology. 2003; 125 (6): 1591-7.
16. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F., Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res. 1995; 10 (2): 250-6.
17. Jahnsen J, Falch JA, Aadland E, Mowinckel P., Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut. 1997; 40 (3): 313-9.
18. Jahnsen J, Falch JA, Mowinckel P, Aadland E., Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol. 2004; 39 (2): 145-53.
19. Targownik LE, Bernstein CN, Leslie WD, Nugent Z., The relationship between inflammatory bowel disease and bone mineral density. Results of a population-based study. Am J Gastroenterol. 2011; 106 (S2): S492.
20. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A., Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999; 149 (10): 916-24.
21. Leslie WD, Caetano PA, Macwilliam LR, Finlayson GS., Construction and validation of a population-based bone densitometry database. J Clin Densitom. 2005; 8 (1): 25-30.
22. Kozyrskyj AL, Mustard CA., Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998; 32 (11): 1152-7.
23. Lix LM, Azimaee M, Acan Osman B, Caetano P, Morin S, Metge C, Goltzman D, Kreiger N, Prior J, Leslie WD., Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health. 2012; 12 (1): 301.
24. Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP., Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997; 12 (11): 1761-178.
25. Leslie WD., The importance of spectrum bias on bone density monitoring in clinical practice. Bone. 2006; 39 (2): 361-8.
26. Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA., Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int. 2011; 22 (3): 817-27.
27. Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD., CaMos Research Group. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int. 2011; 22 (3): 829-37.
28. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD., Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010; 182 (17): 1864-73.
29. Dawson-Hughes B., A revised clinician's guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab. 2008; 93 (7): 2463-5.
30. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD., A note on competing risks in survival data analysis. Br J Cancer. 2004; 91 (7): 1229-35.
31. Bernstein CN, Blanchard JF, Metge C, Yogendran M., The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol. 2003; 98 (8): 1797-801.
32. Card T, West J, Hubbard R, Logan RF., Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut. 2004; 53 (2): 251-5.
33. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS., Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology. 1998; 114 (5): 902-11.
34. Ghosh S, Cowen S, Hannan WJ, Ferguson A., Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology. 1994; 107 (4): 1031-9.